Medikit Co Stock

Medikit Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medikit Co (7749.T) as of Aug 26, 2026 is 4.82 B JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 5.01 B JPY — a change of -3.66% (lower).

EBITDA

4.82 BJPY

YoY

-3.66%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medikit Co is 2026 4.82 B JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medikit Co was 2025 5.01 B JPY. It decreases by -3.66% lower compared to the previous year.

The Medikit Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
3.78 B JPY
Jan 1, 2019
4.10 B JPY
Jan 1, 2020
4.56 B JPY
Jan 1, 2021
4.00 B JPY
Jan 1, 2022
4.65 B JPY
Jan 1, 2023
4.39 B JPY
Jan 1, 2024
5.01 B JPY
Jan 1, 2025
4.82 B JPY
The Medikit Co EBITDA history
YEAREBITDAYoY
4.82 BJPY-3.66%
5.01 BJPY+14.11%
4.39 BJPY-5.76%
4.65 BJPY+16.24%
4.00 BJPY-12.18%
4.56 BJPY+11.28%
4.10 BJPY+8.49%
3.78 BJPY+3.99%
3.63 BJPY-2.27%
3.72 BJPY+4.12%
3.57 BJPY+8.16%
3.30 BJPY
Access this data via the Eulerpool API

Medikit Co Stock analysis

What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medikit Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medikit Co is 4.82 B JPY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medikit Co changed from 5.01 B JPY to 4.82 B JPY, representing a -3.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medikit Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medikit Co historically and in real time.

Access this data via the Eulerpool API

Income Statement — Medikit Co

All Key Metrics — Medikit Co